vyne stock forecast zacks

Get a real-time VYNE Therapeutics Inc. The forecasts range from a low of 150 to a high.

Will Alignment Healthcare Alhc Report Negative Earnings Next Week What You Should Know April 28 2022 Zacks Com

According to 12 stock analysts the average 12-month stock price forecast for VYNE stock is 479 which predicts an increase of 1816.

. The 3 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 400 with a high estimate of 500 and a low estimate of 150. This compares to loss of 035 per. Stock Price Forecast.

Zacks Investment Research upgraded shares of VYNE Therapeutics NASDAQVYNE from a sell rating to a hold rating in a report published on Thursday morning. VYNE came out with a quarterly loss of 013 per share versus the Zacks Consensus Estimate of a loss of 015. Every week Tracey will be.

View the latest VYNE stock quote and chart on MSN Money. The Zacks Equity Research reports or ZER for short are our in-house independently produced research reports. Dive deeper with interactive charts and top stories of VYNE THERAPEUTICS INC.

VYNE Therapeutics Inc. For Immediate ReleaseChicago IL October 14 2022 Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Based on short-term price targets offered by four analysts the average price target for VYNE Therapeutics Inc.

The ever popular one-page Snapshot reports are. VYNE stock price quote with breaking news financials statistics charts and more.

Vyne Therapeutics Inc Nasdaq Vyne Are Analysts Optimistic